The optimal second-line therapy for older adults with type 2 diabetes mellitus: protocol for a systematic review and network meta-analysis using individual participant data (IPD)

Background: Due to increasing life expectancy, almost half of people with type 2 diabetes are aged 65 years or over worldwide. When metformin alone does not control blood sugar, the choice of which second-line therapy to prescribe next is not clear from currently available evidence. The existence of...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Wang, J, Nirantharakumar, K, Sainsbury, C, Moore, DJ, Sinclair, A, Thomas, GN, Hanif, W, Singh, M, Tan, L, Wang, Z, Simms-Williams, N, Yao, M, Gunathilaka, MN, Singh, P, Toulis, K, Tsapas, A, Coomar, D, Price, MJ
বিন্যাস: Journal article
ভাষা:English
প্রকাশিত: BioMed Central 2024

অনুরূপ উপাদানগুলি